A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma

  • Janice M. Mehnert
  • , Ann W. Silk
  • , J. H. Lee
  • , Liesel Dudek
  • , Byeong Seon Jeong
  • , Jiadong Li
  • , Jason M. Schenkel
  • , Evita Sadimin
  • , Michael Kane
  • , Hongxia Lin
  • , Weichung J. Shih
  • , Andrew Zloza
  • , Suzie Chen
  • , James S. Goydos

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology